Hannah D G F Lehman

Title: Innovator Spotlight: Hannah D. G. F. Lehman

Introduction

Hannah D. G. F. Lehman, an accomplished inventor located in Boyertown, PA, has made significant contributions to the field of pharmaceutical innovation. With an impressive portfolio of two patents, her work primarily focuses on novel compounds that exhibit selective activity in voltage-gated sodium channels.

Latest Patents

Hannah's latest patents include groundbreaking research on:

1. **Benzoxazolinone Compounds with Selective Activity in Voltage-Gated Sodium Channels**: This patent discloses compounds of Formula A or their salts, which possess properties for blocking Na1.7 ion channels found in peripheral and sympathetic neurons. It also details pharmaceutical formulations that utilize these compounds, alongside methods for treating neuropathic pain disorders.

2. **N-Substituted Indazole Sulfonamide Compounds with Selective Activity in Voltage-Gated Sodium Channels**: This patent focuses on novel compounds defined by Formula A and Formula A. These compounds also target Na1.7 ion channels in peripheral and sympathetic neurons, with additional insights into corresponding pharmaceutical formulations and therapeutic approaches for managing neuropathic pain.

Career Highlights

Hannah is currently employed at Merck Sharp & Dohme Corporation, a leading biopharmaceutical company dedicated to researching and developing innovative solutions for healthcare challenges. Her expertise in pharmaceutical sciences has propelled her to the forefront of research in pain management, showcasing her commitment to improving patient outcomes through her inventions.

Collaborations

Throughout her career, Hannah has collaborated with esteemed colleagues such as Joseph E. Pero and Michael J. Kelly III. These partnerships reflect her dedication to interdisciplinary research and innovation, contributing to the advancement of drug discovery and development.

Conclusion

Hannah D. G. F. Lehman stands out as a pioneering inventor in the realm of pharmacology. Her patents represent significant strides in outlining new treatment pathways for neuropathic pain, demonstrating her unwavering commitment to healthcare innovation. Her contributions continue to inspire the next wave of researchers and inventors in the pharmaceutical landscape.